Bone Loss in the HIV-Infected Patient: Evidence, Clinical Implications, and Treatment Strategies

Low Vitamin D among HIV-Infected Adults: Prevalence of and Risk Factors for Low Vitamin D Levels in a Cohort of HIV-Infected Adults and Comparison to Prevalence among Adults in the US General Population

(2011) C. N. Dao et al.   CLINICAL INFECTIOUS DISEASES

Increased Rates of Bone Fracture Among HIV-Infected Persons in the HIV Outpatient Study (HOPS) Compared With the US General Population, 2000-2006

(2011) B. Young et al.   CLINICAL INFECTIOUS DISEASES

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

(2011) Michael F. Holick et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

(2011) Grace A. McComsey et al.   JOURNAL OF INFECTIOUS DISEASES

Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans

(2011) Julie A. Womack et al.   PLoS One

Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase

(2010) Tanya Welz et al.   AIDS

Short Communication: Inadequate Vitamin D Exacerbates Parathyroid Hormone Elevations in Tenofovir Users

(2010) Kathryn E. Childs et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D

(2010) Todd T Brown et al.   ANTIVIRAL THERAPY

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

(2010) Hans‐Jürgen Stellbrink et al.   CLINICAL INFECTIOUS DISEASES

Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers

(2010) Grace A. McComsey et al.   CLINICAL INFECTIOUS DISEASES

Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women

(2010) Kerrie M. Sanders et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

(2009) Claudine Duvivier et al.   AIDS

Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen

(2009) Todd T Brown et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Reverse transcriptase inhibitors induce cell differentiation and enhance the immunogenic phenotype in human renal clear-cell carcinoma

(2008) Matteo Landriscina et al.   INTERNATIONAL JOURNAL OF CANCER

Fracture Prevalence among Human Immunodeficiency Virus (HIV)-InfectedVersusNon-HIV-Infected Patients in a Large U.S. Healthcare System

(2008) Virginia A. Triant et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-  and IL-17

(2008) M. Hashizume et al.   RHEUMATOLOGY